Tumor Size on Abdominal MRI Versus Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiation Treatment Planning

Jemal, 2010, Cancer statistics, 2010, CA: Cancer J Clin, 60, 277 Huguet, 2009, Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review, J Clin Oncol, 27, 2269, 10.1200/JCO.2008.19.7921 Krishnan, 2007, Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy, Cancer, 110, 47, 10.1002/cncr.22735 Ko, 2007, A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 68, 809, 10.1016/j.ijrobp.2007.01.005 Iacobuzio-Donahue, 2009, DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer, J Clin Oncol, 27, 1806, 10.1200/JCO.2008.17.7188 Schellenberg, 2011, Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 81, 181, 10.1016/j.ijrobp.2010.05.006 Koong, 2004, Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 58, 1017, 10.1016/j.ijrobp.2003.11.004 Chang, 2009, Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas, Cancer, 115, 665, 10.1002/cncr.24059 Ben-Josef, 2004, Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer, Int J Radiat Oncol Biol Phys, 59, 454, 10.1016/j.ijrobp.2003.11.019 Schellenberg, 2008, Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 72, 678, 10.1016/j.ijrobp.2008.01.051 Arvold, 2011, Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning, Int J Radiat Oncol Biol Phys, 80, 1383, 10.1016/j.ijrobp.2010.04.058 Lee, 2010, Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma, Eur J Radiol, 73, 310, 10.1016/j.ejrad.2008.10.028 Willett, 2005, Locally advanced pancreatic cancer, J Clin Oncol, 23, 4538, 10.1200/JCO.2005.23.911 Brade, 2007, Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study, Int J Radiat Oncol Biol Phys, 67, 1027, 10.1016/j.ijrobp.2006.10.015 Tamm, 2012, Imaging of pancreatic adenocarcinoma: update on staging/resectability, Radiol Clin North Am, 50, 407, 10.1016/j.rcl.2012.03.008 Lauenstein, 2010, Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging, Pancreas, 39, 71, 10.1097/MPA.0b013e3181b9ed55 Park, 2009, Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT, J Magn Reson Imaging, 30, 586, 10.1002/jmri.21889 Ichikawa, 1997, Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging, Radiology, 202, 655, 10.1148/radiology.202.3.9051012 Megibow, 1995, Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability: report of the Radiology Diagnostic Oncology Group, Radiology, 195, 327, 10.1148/radiology.195.2.7724748 Serrano, 2010, The role of PET scanning in pancreatic cancer, Adv Surg, 44, 313, 10.1016/j.yasu.2010.05.007